St. Jude Medical has received FDA regulatory clearance for the firm’s new five-column neurostimulation lead. The Penta™, being unveiled at North American Neuromodulation Society meeting, sports the market’s smallest electrodes arranged in five columns.
This innovative surgical lead provides the broadest lateral electrode span of any neurostimulation lead on the market — yet the paddle configuration is only 10.9 mm wide. The Penta lead’s unique design is made possible by a proprietary micro-texturing process which enables greater amounts of current to be delivered via the small electrodes. The result is a lead that can more specifically focus current over a greater lateral area of the spinal cord, which may provide better coverage for managing hard to control chronic pain.
Press release: St. Jude Medical Receives FDA Approval for Industry-First Five-Column Neurostimulation Lead to Manage Chronic Pain…
